Reneo Pharmaceuticals: Rises after director buys stake

Onkure Therapeutics

28/05/2021 23:54

** Drug developer's shares  RPHM.O  up 15.9% at $11.20 after
market
    ** RPHM up after Director Bali Muralidhar buys 7,035 shares
of company for $65,864.40 (https://bit.ly/2RUIq5p)
    ** Muralidhar bought 5,915 shares for $9.38/shr on Wednesday
and 1,120 shares for $9.26/shr on Thursday
    ** Stock down 27.6% since company debuted in April

 (Reporting by Sahil Shaw in Bengaluru)
 ((sahil.shaw@thomsonreuters.com))